Company
Company description
Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agriculture, food, consumer products, and pharmaceuticals. Ginkgo Bioworks has a partnership with Selecta Biosciences, Inc. to develop ImmTOR technology platform. Ginkgo Bioworks Holdings, Inc. was founded in 2008 and is headquartered in Boston, Massachusetts.
Quick Presentation Filters

Filter

      Loading ...

      Loading ...

      Loading ...

Filter

      Loading ...

      Loading ...

      Loading ...

Presentations (10)
Results
August 2022
40 slides
Mergers and Acquisitions
July 2022
16 slides
Results
May 2022
37 slides
Results
March 2022
41 slides
Investor Conference
January 2022
23 slides
Results
November 2021
36 slides
Results
August 2021
30 slides
Investor Conference
June 2021
38 slides
Investor Conference
June 2021
43 slides
SPAC
May 2021
66 slides
Search Thousands of Presentations by World Leading Companies

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases
© 2021-2024 Slidebook.io